Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP8 | P22894 | 3/20 | 0.58 |
| ▸ | CA12 | O43570 | 1/20 | 0.56 |
| ▸ | CA1 | P00915 | 1/20 | 0.56 |
| ▸ | CA2 | P00918 | 1/20 | 0.56 |
| ▸ | CA3 | P07451 | 1/20 | 0.56 |
| ▸ | CA4 | P22748 | 1/20 | 0.56 |
| ▸ | CA6 | P23280 | 1/20 | 0.56 |
| ▸ | CA5A | P35218 | 1/20 | 0.56 |
| ▸ | CA7 | P43166 | 1/20 | 0.56 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.56 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.56 |
| ▸ | CA9 | Q16790 | 1/20 | 0.56 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.56 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.56 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.54 |
| ▸ | MME | P08473 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20804412 | 0.87 | POLB (0.57) | MMP8CA12CA1CA2CA3 | |
| SCHEMBL14947756 | 0.87 | POLB (0.57) | MMP8CA12CA1CA2CA3 | |
| SCHEMBL8769547 | 0.85 | MMP8 (0.59) | MMP8CA12CA1CA2CA3 | |
| SCHEMBL8205298 | 0.84 | CA12 (0.74) | MMP8CA12CA1CA2CA3 | |
| SCHEMBL47275 | 0.84 | CA12 (0.74) | MMP8CA12CA1CA2CA3 | |
| SCHEMBL2600863 | 0.84 | CA12 (0.74) | MMP8CA12CA1CA2CA3 | |
| SCHEMBL1697369 | 0.84 | CA12 (0.74) | MMP8CA12CA1CA2CA3 | |
| SCHEMBL18435455 | 0.84 | MMP8 (0.55) | MMP8CA12CA1CA2CA3 | |
| SCHEMBL12505312 | 0.83 | MMP8 (0.61) | MMP8CA12CA1CA2CA3 | |
| SCHEMBL20720018 | 0.83 | MMP8 (0.61) | MMP8CA12CA1CA2CA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120095251-A1 | Process for Producing Lacosamide | EUTICALS GMBH (DE) | 2012-04-19 | — | — | US | disclosed |
| US-20110319649-A1 | Intermediate for producing lacosamide and a process for its preparation and conversion to lacosamide | EUTICALS GMBH (DE) | 2011-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110319649-A1 | Intermediate for producing lacosamide and a process for its preparation and conversion to lacosamide | NAAA, MEP1B, BCHE | MMP8 1953/4885CA12 138/4885CA1 11/4885 |
| US-20120095251-A1 | Process for Producing Lacosamide | NAAA, TET3, GNMT | MMP8 2694/4885CA12 168/4885CA1 126/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.